Myeloma and second primary cancers

N Engl J Med. 2011 Dec 8;365(23):2241-2. doi: 10.1056/NEJMc1111010.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Lenalidomide
  • Leukemia, Myeloid / etiology
  • Melphalan / administration & dosage
  • Melphalan / adverse effects
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Myelodysplastic Syndromes / etiology
  • Neoplasms, Second Primary / etiology*
  • Probability
  • Risk Assessment
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide
  • Melphalan